Solid Biosciences Inc
SLDBHealthcare|Biotechnology|USA
$10.40
-0.71 (-6.38%)
Tangible Book
$3.80
Earnings Power
$3.33
About
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Stock Price
+92.0%(1Y)
Pipeline Summary
19 total trials4
Phase 1
7
Phase 2
8
Phase 3
0
Phase 4
Recruiting: 4Active: 1Completed: 9Unknown: 3Terminated: 2
Active Trials (5)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
NCT07160634Duchenne Muscular Dystrophy
Phase 3Recruiting
Enrollment: 80 participants
Microdystrophin Gene Transfer Study in Adolescents and Children With DMD
NCT03368742Duchenne Muscular Dystrophy
Phase 1Phase 2Active
Enrollment: 12 participants
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
NCT06138639Duchenne Muscular Dystrophy
Phase 1Phase 2Recruiting
Enrollment: 60 participants
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
NCT07180355Friedreich's Ataxia (FA)
Phase 1Recruiting
Enrollment: 10 participants
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT07148089Catecholaminergic Polymorphic Ventricular Tachycardia
Phase 1Recruiting
Enrollment: 18 participants
BioScore
5.1/10
Watchlist
Ownership
Recent Insider Trades
Cumbo AlexanderSELL
2026-02-1816,644 shares @ $5.82
Hanrahan JessieSELL
2026-02-184,134 shares @ $5.82
Howton David TSELL
2026-02-187,469 shares @ $5.82
Tan KevinSELL
2026-02-185,404 shares @ $5.82
Ganot IlanSELL
2026-02-182,658 shares @ $5.82
Recent News
2026-07-01 00:35:49
Data last updated: Jul 13, 2026, 12:48 PM